Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Objectives: Concurrent intraductal papillary-mucinous neoplasm (IPMN) and autoimmune pancreatitis (AIP) was observed in a patient (index case) at our institution. Cases of coincidental IPMN and type 1 AIP and concurrent ductal adenocarcinoma (PDAC) and AIP have been previously reported. In this study we evaluate the hypothesis that IPMN elicits an IgG4 response.
Methods: Twenty-one pancreases (including the index case) with IPMN resected at our institution were studied. H&E stained slides were reviewed and blocks of peritumoral pancreas were immunostained with IgG4 to look for IgG4-positive plasma cells.
Results: We found evidence of variable IgG4 overexpression in 4/21 (19%) of IPMN. These included the index case and three others without stigmata of AIP.
Conclusion: A small subset of pancreatic neoplasms including intraductal papillary-mucinous neoplasms (IPMN) is associated with an IgG4 autoimmune response that sometimes progresses to peritumoral type 1 AIP and less often to diffuse AIP and IgG4-related systemic disease.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.pan.2017.02.004 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
MRI at 0.55 T for Assessment of Pancreatic Intraductal Papillary Mucinous Neoplasms: An Intraindividual Comparison Versus 1.5-T and 3-T MRI.
AJR Am J Roentgenol
September 2025
Professor, Department of Radiology, Division of Abdominal Radiology University of Michigan and Michigan Medicine.
Mid-field (0.55-T) MRI may offer an alternative to higher field strengths for pancreatic intraductal papillary mucinous neoplasms (IPMNs) surveillance given high-quality MRCP sequences enabled by longer T2 relaxation times and greater patient comfort resulting from a larger bore and reduced acoustic noise. However, SNR is lower at 0.
View Article and Find Full Text PDFEndoscopic retrograde direct pancreatoscopy in diagnosis and mapping of intraductal papillary mucinous neoplasm.
Gastrointest Endosc
September 2025
Department of Gastroenterology and Hepatology, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan Province, China. Electronic address:
Predicting textbook outcome after pancreaticoduodenectomy for invasive intraductal papillary mucinous neoplasm: An international validation cohort study.
Surgery
August 2025
General Surgery, Cancer Center, Department of Hepatobiliary & Pancreatic Surgery and Minimally Invasive Surgery, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China. Electronic address:
Background: Textbook outcome, a composite measure of optimal recovery, remains poorly defined for invasive intraductal papillary mucinous neoplasm after pancreaticoduodenectomy. This study aimed to develop and validate the first nomogram predicting textbook outcome in this distinct cohort, addressing gaps in tailored prognostic tools for patients meeting contemporary surgical criteria on the basis of high-risk features.
Methods: Using multicenter data from 327 US patients (training cohort) and 152 Chinese patients (external test cohort), we evaluated 43 preoperative and intraoperative variables.
Multi-omic profiling of intraductal papillary neoplasms of the pancreas reveals distinct patterns and potential markers of progression.
Cancer Cell
August 2025
Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA; Department of Oncology, Sol Goldman Pancreatic Cancer Research Center, Sidney Kimmel Cancer Center, Johns Hopkins University School of Medicine, Baltimore, M
To enable early detection of pancreatic cancer from precancerous lesions, we analyze proteins and glycoproteins from 64 intraductal papillary mucinous neoplasms (IPMNs), 55 cyst fluid samples, 104 pancreatic ductal adenocarcinomas (PDACs), and various types of normal samples using mass spectrometry. High-grade IPMNs show enrichment of glycosylation level and tumor progression pathways compared to low-grade lesions. High-grade IPMN associated proteins, such as PLOD3, IRS2, LGALS9, and Trop-2, are identified and validated using immunolabeling and laser microdissection.
View Article and Find Full Text PDFThe Differential Diagnosis and Management of Pancreatic Cystic Neoplasms.
Dtsch Arztebl Int
November 2025
Background: The prevalence of pancreatic cyst lesions in the general population worldwide is 16%. The majority of these cysts are intraductal papillary mucinous neoplasms (IPMN), which are associated with a risk of developing pancreatic cancer. In this article, we summarize the current knowledge of the differential diagnosis and management of cystic pancreatic neoplasia.
View Article and Find Full Text PDF